Latest Payments News

Li-FT Power has signed a definitive agreement to acquire Azimut Exploration's 50% interest in the Galinée lithium property, a crucial step enabling its planned takeover of Winsome Resources. This deal strengthens Li-FT's position in Quebec's lithium sector alongside Winsome's flagship Adina project.

Westpac Banking Corporation has announced a fully franked distribution of AUD 1.1789 per Westpac Capital Notes 10 for the quarter ending March 2026, reflecting a 4.78% annualised yield based on current market rates.

Weebit Nano has inked a long-term licensing deal with semiconductor giant Texas Instruments to integrate its advanced ReRAM technology into TI’s embedded processing chips, marking a significant step for next-generation memory solutions.

Indiana Resources has resolved its long-standing arbitration dispute with Tanzania, clearing the way to concentrate on its promising Australian gold exploration projects.

BlackRock Investment Management (Australia) Limited has announced key distribution dates for its suite of Australian iShares ETFs, including important deadlines for investors to participate in the Distribution Reinvestment Plan and comply with tax certification requirements.

Jayride Group Limited reports a reduced quarterly loss and secures fresh capital, yet faces ongoing uncertainty over its ability to continue as a going concern during its ASX reinstatement process.

JAYRIDE Group has amended its quarterly cash flow report to correct classification errors, while outlining plans for a new SaaS platform rollout and potential capital raising to support operations.

Austral Gold has inked major mining service agreements to advance open pit operations at its Casposo Mine, aligning with its 2026 production targets. Early production is on track, underpinning confidence in the company’s growth trajectory.

The Lederer Group, holding 42.7% of Elanor Commercial Property Fund securities, is pushing to replace the fund’s responsible entity and manager, aiming to reduce management fees and reshape governance.

Racura Oncology has appointed Beyond Drug Development to oversee its HARNESS-1 Phase 1a/b trial combining RC220 with osimertinib in EGFR-mutated non-small cell lung cancer patients, marking a key step toward clinical advancement.

Elanor Investors Group has agreed to step down as manager of the Elanor Commercial Property Fund, accepting $8.5 million in compensation as Lederer Group moves to assume control. The transition promises fee savings and closer alignment with investors.

DroneShield has landed a $6.2 million contract through a key reseller for delivery to a military client in the Asia Pacific region, continuing its steady revenue stream from this partner.